Clinical trial

Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children

NCT00000876

Study summary

ClinicalTrials.gov

Safety and Effectiveness of CD4-IgG2 in HIV-Positive Children

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention CD4-IgG2 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start dateUnknown

PhasePHASE1

Conditions

HIV Infectionsunresolved

Interventions

CD4-IgG2DRUG

Sponsors & collaborators

National Institute of Allergy and Infectious Diseases (NIAID)lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)collaborator

Mapped research locations

Los AngelesCalifornia, United States2 HoustonTexas, United States1 San FranciscoCalifornia, United States1 Washington D.C.District of Columbia, United States1 JacksonvilleFlorida, United States1 Long BeachCalifornia, United States1 OrangeCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00000876 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.